AXL inhibition was also reported to induce HR deficiency, leading to synergistic effects when combined with PARP1 inhibition in high AXL-expressing TNBC, NSCLC and HNSCC cell lines16. Here, PARP1 is linked to head and neck squamous cell carcinoma.